SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-021933
Filing Date
2022-11-03
Accepted
2022-11-03 16:32:22
Documents
42
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q mack-20220930.htm   iXBRL 10-Q 1094194
2 EX-31.1 mack-ex31_1.htm EX-31.1 14796
3 EX-31.2 mack-ex31_2.htm EX-31.2 14796
4 EX-32.1 mack-ex32_1.htm EX-32.1 10318
5 EX-32.2 mack-ex32_2.htm EX-32.2 10318
  Complete submission text file 0000950170-22-021933.txt   3265143

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mack-20220930_lab.xml EX-101.LAB 191303
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mack-20220930.xsd EX-101.SCH 23548
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mack-20220930_pre.xml EX-101.PRE 125794
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT mack-20220930_def.xml EX-101.DEF 53753
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT mack-20220930_cal.xml EX-101.CAL 18948
36 EXTRACTED XBRL INSTANCE DOCUMENT mack-20220930_htm.xml XML 422764
Mailing Address ONE BROADWAY 14TH FLOOR CAMBRIDGE MA 02142
Business Address ONE BROADWAY 14TH FLOOR CAMBRIDGE MA 02142 617-441-1000
MERRIMACK PHARMACEUTICALS INC (Filer) CIK: 0001274792 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35409 | Film No.: 221358577
SIC: 2834 Pharmaceutical Preparations